<DOC>
	<DOC>NCT00185107</DOC>
	<brief_summary>Assess the efficacy of WelChol® plus Zetia® in treating patients with high cholesterol</brief_summary>
	<brief_title>Effect of Combination Therapy With Two Drugs (Colesevelam and Ezetimibe) in Patients With High Cholesterol</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Colesevelam Hydrochloride</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>1880 years of age, inclusive; A history of primary hypercholesterolemia Any serious disorders including pulmonary, hepatic, renal, gastrointestinal (including clinically significant malabsorption), uncontrolled endocrine/ metabolic, hematologic/oncologic (within the last 5 years), neurologic and psychiatric diseases that would interfere with the conduct of the study or interpretation of the data; Hepatic dysfunction including biliary cirrhosis, unexplained persistent liver function abnormality, and preexisting gallbladder disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2007</verification_date>
	<keyword>Safety</keyword>
	<keyword>Efficacy</keyword>
	<keyword>WelChol®</keyword>
	<keyword>Zocor®</keyword>
	<keyword>Zetia®</keyword>
</DOC>